Paul Waring

Paul Waring

UNVERIFIED PROFILE

Are you Paul Waring?   Register this Author

Register author
Paul Waring

Paul Waring

Publications by authors named "Paul Waring"

Are you Paul Waring?   Register this Author

87Publications

2323Reads

42Profile Views

19q12 amplified and non-amplified subsets of high grade serous ovarian cancer with overexpression of cyclin E1 differ in their molecular drivers and clinical outcomes.

Gynecol Oncol 2018 11 9;151(2):327-336. Epub 2018 Sep 9.

Centre for Translational Pathology, Department of Pathology, University of Melbourne, Parkville, Victoria 3010, Australia; Department of Surgery, University of Melbourne, Parkville, Victoria 3010, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2018.08.039DOI Listing
November 2018

Optimizing Amplification of the GC-Rich Promoter Region Using 7-Deaza-dGTP for Droplet Digital PCR Quantification of Promoter Mutations.

Clin Chem 2018 04 30;64(4):745-747. Epub 2018 Jan 30.

Department of Pathology, University of Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2017.284257DOI Listing
April 2018

Intratumorous heterogeneity for RAS mutations in a treatment-naïve colorectal tumour.

J Clin Pathol 2017 Aug 17;70(8):720-723. Epub 2017 Mar 17.

Department of Pathology, University of Melbourne, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2017-204327DOI Listing
August 2017

Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM Study.

J Clin Oncol 2016 07 25;34(19):2258-64. Epub 2016 Apr 25.

Eva Segelov, St Vincent's Clinical School, University of New South Wales; Subotheni Thavaneswaran, Kristy P. Robledo, Val J. Gebski, Mustafa Khasraw, Kate Wilson, and John Simes, National Health and Medical Research Council Clinical Trials Centre (NHMRC), University of Sydney; Lorraine A. Chantrill, Macarthur Cancer Therapy Centre, Campbelltown Hospital and Kinghorn Cancer Centre; Nick Pavlakis and Mustafa Khasraw, Royal North Shore Hospital University of Sydney, Sydney; Paul M. Waring and Sebastian Lunke, Centre for Translational Pathology, University of Melbourne; Jayesh Desai, Royal Melbourne Hospital; Jayesh Desai and Michael Jefford, Peter MacCallum Cancer Centre; Andrew Haydon, Alfred Hospital; Jeremy D. Shapiro, Cabrini Hospital, Melbourne; Louise M. Nott, Royal Hobart Hospital, Hobart; Christos S. Karapetis, Flinders University and Flinders Medical Centre; Timothy J. Price, Queen Elizabeth Hospital and Lyell McEwin Hospital, Adelaide; Craig Underhill, Border Medical Oncology, Albury-Wodonga; Guy van Hazel, Sir Charles Gairdner Hospital, Perth, Australia; Elena Elez, Vall d'Hebron University Hospital, Barcelona, Spain; Fortunato Ciardiello, Seconda Università degli Studi di Napoli, Naples, Italy; and Harpreet Wasan, Hammersmith Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.6843DOI Listing
July 2016

Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer.

Oncoimmunology 2016 Jul 29;5(7):e1149667. Epub 2016 Jun 29.

Peter MacCallum Cancer Center and The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne ,Victoria, Australia; The Department of Pathology, University of Melbourne, Melbourne Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1149667DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006930PMC
July 2016

RAS Mutations as Predictive Biomarkers in Clinical Management of Metastatic Colorectal Cancer.

Clin Colorectal Cancer 2016 06 11;15(2):95-103. Epub 2015 Nov 11.

Flinders University, Flinders Centre for Innovation in Cancer, Flinders Medical Centre, Adelaide, South Australia, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2015.10.006DOI Listing
June 2016

Incorporating traditional and emerging biomarkers in the clinical management of metastatic colorectal cancer.

Expert Rev Mol Diagn 2015 12;15(8):1033-48. Epub 2015 Jul 12.

Flinders Medical Centre, Sturt Road, Bedford Park, South Australia 5042, Australia.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/14737159.2015.10
Publisher Site
http://dx.doi.org/10.1586/14737159.2015.1052797DOI Listing
April 2016

Stomach-Specific Activation of Oncogenic KRAS and STAT3-Dependent Inflammation Cooperatively Promote Gastric Tumorigenesis in a Preclinical Model.

Cancer Res 2016 04 2;76(8):2277-87. Epub 2016 Feb 2.

Cancer and Inflammation, Olivia Newton-John Cancer Research Institute and School of Cancer Medicine La Trobe University, Heidelberg, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-3089DOI Listing
April 2016

Sensitivity of blood lipids to changes in adiposity, exercise, and diet in children.

Med Sci Sports Exerc 2015 May;47(5):974-82

1UC Research Institute for Sport and Exercise, Faculty of Health, University of Canberra, Bruce, ACT, AUSTRALIA; 2Clinical Trials Unit, Canberra Hospital, Garran, ACT, AUSTRALIA; 3Fenner School of Environment and Society, Australian National University, Canberra, ACT, AUSTRALIA; 4Department of Chemistry, Faculty of Science, Australian National University, Canberra, ACT, AUSTRALIA; 5Center for Research and Action in Public Health, Faculty of Health, University of Canberra, Bruce, ACT, AUSTRALIA; and 6College of Medicine, Biology, and Environment, Australian National University, Canberra, ACT, AUSTRALIA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1249/MSS.0000000000000493DOI Listing
May 2015

Whole-genome characterization of chemoresistant ovarian cancer.

Nature 2015 May;521(7553):489-94

1] Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia [2] Department of Pathology, University of Melbourne, Parkville, Victoria 3052, Australia [3] Sir Peter MacCallum Cancer Centre Department of Oncology, University of Melbourne, Parkville, Victoria 3052, Australia [4] Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London W12 0HS, UK [5] Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria 3052, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature14410DOI Listing
May 2015

Ubiquitous expression of the Pik3caH1047R mutation promotes hypoglycemia, hypoinsulinemia, and organomegaly.

FASEB J 2015 Apr 30;29(4):1426-34. Epub 2014 Dec 30.

*Surgical Oncology Research Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia; University of Melbourne Department of Medicine, Austin Health, Heidelberg, Victoria, Australia; Translational Research Laboratories, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; St. Vincent's Institute of Medical Research and University of Melbourne Department of Medicine, St. Vincent's Hospital, Fitzroy, Victoria, Australia; Bone Research Program, ANZAC Research Institute, The University of Sydney, Sydney, New South Wales, Australia; Differentiation and Transcription Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; **Department of Pathology, University of Melbourne, Parkville, Victoria, Australia; Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; and University of Melbourne Department of Surgery, St. Vincent's Hospital, Fitzroy, Victoria, Australia

View Article

Download full-text PDF

Source
http://www.fasebj.org/content/29/4/1426.full.pdf
Web Search
http://www.fasebj.org/cgi/doi/10.1096/fj.14-262782
Publisher Site
http://dx.doi.org/10.1096/fj.14-262782DOI Listing
April 2015

AmpliVar: mutation detection in high-throughput sequence from amplicon-based libraries.

Hum Mutat 2015 Apr 16;36(4):411-8. Epub 2015 Mar 16.

Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/humu.22763DOI Listing
April 2015

EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic survey.

J Thorac Oncol 2015 Mar;10(3):438-45

*Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan; †Department of Pathology, Aberdeen University Medical School, Aberdeen, United Kingdom; ‡KalGen Laboratory, Stem-cell and Cancer Institute (SCI), Jakarta, Indonesia; §School of Medicine, Monash University Malaysia & Sime Darby Medical Center, Kuala Lumpur, Malaysia; ‖Center for Gene and Protein Research, Hanoi Medical University, Hanoi, Vietnam; ¶Department of Pathology, Fudan University Shanghai Cancer Center; Institute of Pathology, Fudan University, Shanghai, China; #Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; **Research and Biotechnology Division, St. Luke's Medical Center, Quezon City & COS-CENSER, De La Salle University, Manila, Philippines; ††Department of Pathology, National Cancer Center, Goyang-si, Gyeonggi-do, Korea; ‡‡Department of Pathology, Singapore General Hospital, Singapore, Singapore; §§Chulalongkorn GenePRO Center, Chulalongkorn Hospital, Bangkok, Thailand; ‖‖Seoul National University Bundang Hospital, Seoul, Korea; ¶¶Department of Respiratory Medicine, Saitama Medical University, Saitama, Japan; ##Peking Union Medical College Hospital, Beijing, China; ***Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione Giovanni Pascale" - IRCCS, Naples, Italy; †††Division of Hematology/Oncology, Innovative Cancer Medicine Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; ‡‡‡Clinical Genomic Medicine/Thoracic Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; §§§Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; ‖‖‖University of Melbourne, Melbourne, VIC, Australia; ¶¶¶Sun Yat-Sen University Cancer Center, Guangzhou, China; ###Personalised Healthcare, AstraZeneca, Macclesfield, United Kingdom; ****Clinical Science Division, Astr

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000422DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342317PMC
March 2015

Applicability of next generation sequencing technology in microsatellite instability testing.

Genes (Basel) 2015 Feb 12;6(1):46-59. Epub 2015 Feb 12.

Department of Pathology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Victoria 3052, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/genes6010046DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377833PMC
February 2015

Immunohistochemistry with the anti-BRAF V600E (VE1) antibody: impact of pre-analytical conditions and concordance with DNA sequencing in colorectal and papillary thyroid carcinoma.

Pathology 2014 Oct;46(6):509-17

1Ventana Medical Systems Inc., Roche, Tucson, AZ, USA 2Department of Pathology, St Vincent's Hospital, Melbourne, Vic 3Centre for Cancer Biology, University of South Australia, and Department of Anatomical Pathology, SA Pathology, Adelaide, SA 4Department of Pathology, University of Melbourne, Melbourne, Vic, Australia.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00313025163053
Publisher Site
http://dx.doi.org/10.1097/PAT.0000000000000119DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233678PMC
October 2014

KRAS mutation testing of metastatic colorectal cancer in Australia: where are we at?

Asia Pac J Clin Oncol 2014 Sep 9;10(3):261-5. Epub 2014 May 9.

Hunter Area Pathology Service, Newcastle, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12201DOI Listing
September 2014

Physical education and blood lipid concentrations in children: the LOOK randomized cluster trial.

PLoS One 2013 25;8(10):e76124. Epub 2013 Oct 25.

National Institute of Sports Studies, Faculty of Health, University of Canberra, Canberra, Australian Capital Territory, Australia ; Clinical Trials Unit, Academic Unit of Internal Medicine, Canberra Hospital, Garran, Australian Capital Territory, Australia.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0076124PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808412PMC
August 2014

Plasmacytomagenesis in Eμ-v-abl transgenic mice is accelerated when apoptosis is restrained.

Blood 2014 Aug 1;124(7):1099-109. Epub 2014 Jul 1.

The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia; and Departments of Medical Biology and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-04-570770DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133484PMC
August 2014

Characterisation of apoptosis in myb-transformed hematopoietic cell (MTHC-A) lines: TNF-α-induced apoptosis and prevention by cAMP.

J Clin Exp Hematop 2013 ;53(2):115-20

Department of Obstetrics and Gynecology, Dokkyo Medical University, Mibu, Tochigi, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3960/jslrt.53.115DOI Listing
March 2014

Therapeutic inhibition of Jak activity inhibits progression of gastrointestinal tumors in mice.

Mol Cancer Ther 2014 Feb 7;13(2):468-74. Epub 2014 Jan 7.

Corresponding Author: Matthias Ernst, The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-13-0583-TDOI Listing
February 2014

The prognostic significance of the BRAF V600E mutation in papillary thyroid carcinoma detected by mutation-specific immunohistochemistry.

Pathology 2013 12;45(7):637-44

*Departments of Anatomical Pathology †Surgery, St Vincent's Hospital, Melbourne ‡Department of Pathology, University of Melbourne, Melbourne, Victoria, Australia; ‡these authors contributed equally.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAT.0000000000000008DOI Listing
December 2013

Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancer.

Clin Cancer Res 2013 Nov 4;19(21):5960-71. Epub 2013 Sep 4.

Authors' Affiliations: Peter MacCallum Cancer Centre, East Melbourne; Victorian Cancer Cytogenetics Service, St Vincent's Hospital, Melbourne; Sir Peter MacCallum Department of Oncology; Departments of Pathology, Biochemistry and Molecular Biology, and Medicine; Centre for Translational Pathology, University of Melbourne, Parkville, Victoria, Australia; Dana-Farber Cancer Institute, Boston; and The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/early/2013/08/
Web Search
http://clincancerres.aacrjournals.org/content/19/21/5960.ful
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-13-1337DOI Listing
November 2013

Menin and p53 have non-synergistic effects on tumorigenesis in mice.

BMC Cancer 2012 Jun 18;12:252. Epub 2012 Jun 18.

Queensland Institute of Medical Research, 300 Herston Road, Herston, QLD, 4006, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-12-252DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433377PMC
June 2012

SNP-based arrays complement classic cytogenetics in the detection of chromosomal aberrations in Wilms' tumor.

Cancer Genet 2012 Mar;205(3):80-93

School of Pathology and Laboratory Medicine, University of Western Australia, QEII Medical Centre, Nedlands, Western Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergen.2011.12.003DOI Listing
March 2012

Establishment of pediatric reference intervals on a large cohort of healthy children.

Clin Chim Acta 2010 Oct 22;411(19-20):1421-7. Epub 2010 Jun 22.

ACT Pathology, The Canberra Hospital, Canberra, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cca.2010.06.018DOI Listing
October 2010

Perforin-mediated suppression of B-cell lymphoma.

Proc Natl Acad Sci U S A 2009 Feb 5;106(8):2723-8. Epub 2009 Feb 5.

Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0809008106DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2650333PMC
February 2009

Structure-activity delineation of quinones related to the biologically active Calothrixin B.

Bioorg Med Chem Lett 2007 Jan 4;17(1):82-5. Epub 2006 Oct 4.

Department of Chemistry, Australian National University, Canberra, ACT 0200, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2006.09.090DOI Listing
January 2007

Sensitive detection of KIT D816V in patients with mastocytosis.

Clin Chem 2006 Dec 13;52(12):2250-7. Epub 2006 Oct 13.

Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2006.068205DOI Listing
December 2006

Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing.

Am J Surg Pathol 2006 Nov;30(11):1357-66

Division of Tissue Pathology, Institute of Medical and Veterinary Science, Adelaide, South Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.pas.0000213273.22844.1aDOI Listing
November 2006

Matching patients with drugs: triumphs and challenges.

Authors:
Paul M Waring

Per Med 2006 Aug;3(3):335-344

Genentech Inc., 1 DNA Way, South San Francisco, CA 94080-4990, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/17410541.3.3.335DOI Listing
August 2006

Cutting edge: TRAIL deficiency accelerates hematological malignancies.

J Immunol 2005 Nov;175(9):5586-90

Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.175.9.5586DOI Listing
November 2005

The epipolythiodioxopiperazine (ETP) class of fungal toxins: distribution, mode of action, functions and biosynthesis.

Microbiology 2005 Apr;151(Pt 4):1021-1032

School of Botany, The University of Melbourne, Victoria 3010, Australia.

View Article

Download full-text PDF

Source
http://mic.microbiologyresearch.org/content/journal/micro/10
Publisher Site
http://dx.doi.org/10.1099/mic.0.27847-0DOI Listing
April 2005

Redox active calcium ion channels and cell death.

Authors:
Paul Waring

Arch Biochem Biophys 2005 Feb;434(1):33-42

Department of Chemistry, Centre for the Study of Bioactive Molecules, The Faculties, Australian National University, Acton, Canberra, ACT 0200, Australia.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S000398610400447
Publisher Site
http://dx.doi.org/10.1016/j.abb.2004.08.001DOI Listing
February 2005

Scabrosin esters and derivatives: chemical derivatization studies and biological evaluation.

Bioorg Med Chem 2004 Nov;12(22):5991-5

Centre for the Study of Bioactive Molecules, Department of Chemistry, Australian National University, Canberra ACT 0200, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2004.08.015DOI Listing
November 2004

Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: case report.

BMC Cancer 2004 Oct 9;4:74. Epub 2004 Oct 9.

Medical Oncology Unit, Canberra Hospital, :Yamba Drive, Garran, ACT, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-4-74DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC524360PMC
October 2004

Synthesis, electrochemistry, and bioactivity of the cyanobacterial calothrixins and related quinones.

J Med Chem 2004 Sep;47(20):4958-63

Department of Chemistry and School of Biochemistry and Molecular Biology, Centre for the Study of Bioactive Molecules, Australian National University, ACT 0200, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/jm049625oDOI Listing
September 2004

Diagnostic application of Epstein-Barr virus-encoded RNA in situ hybridisation.

Pathology 2004 Aug;36(4):301-8

Department of Pathology, Peter MacCallum Cancer Centre, St Andrew's Place, East Melbourne, Victoria 3002, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0031302042000224584DOI Listing
August 2004

Expression and localization of homeodomain proteins DLX4, HB9 and HB24 in malignant and benign human colorectal tissues.

Anticancer Res 2004 Mar-Apr;24(2B):955-62

Dame Roma Mitchell Cancer Research Laboratories, University of Adelaide, Hanson Institute, IMVS, Adelaide, South Australia, Australia.

View Article

Download full-text PDF

Source
July 2004

A novel redox mechanism for the glutathione-dependent reversible uptake of a fungal toxin in cells.

J Biol Chem 2003 Nov 28;278(47):46549-55. Epub 2003 Aug 28.

Centre for the Study of Bioactive Molecules, Department of Chemistry, The Faculties, Australian National University, Canberra 0200, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M304825200DOI Listing
November 2003

Evidence that the lichen-derived scabrosin esters target mitochondrial ATP synthase in P388D1 cells.

Toxicol Appl Pharmacol 2003 Aug;190(3):232-40

John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0041-008x(03)00189-3DOI Listing
August 2003

Alternative mammary oncogenic pathways are induced by D-type cyclins; MMTV-cyclin D3 transgenic mice develop squamous cell carcinoma.

Oncogene 2003 Jul;22(28):4425-33

Peter MacCallum Cancer Institute, Trescowthick Research Laboratories, St Andrew's Place, East Melbourne, Victoria 3002, Australia.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/1206488
Publisher Site
http://dx.doi.org/10.1038/sj.onc.1206488DOI Listing
July 2003

Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer.

Cancer Res 2003 May;63(10):2569-77

Trescowthick Research Laboratories, Peter MacCallum Cancer Institute, Melbourne, Victoria, 8006, Australia.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/content/63/10/2569.full.pd
Web Search
May 2003

Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer.

Nat Genet 2002 Sep 26;32(1):185-90. Epub 2002 Aug 26.

Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Herston, 4029, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng958DOI Listing
September 2002

Influx of calcium through a redox-sensitive plasma membrane channel in thymocytes causes early necrotic cell death induced by the epipolythiodioxopiperazine toxins.

J Biol Chem 2002 Aug 12;277(35):31631-8. Epub 2002 Jun 12.

Division of Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University, Canberra 0200, Australian Capital Territory, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M201699200DOI Listing
August 2002

Inactivation of the transcription factor Elf3 in mice results in dysmorphogenesis and altered differentiation of intestinal epithelium.

Gastroenterology 2002 May;122(5):1455-66

Centre for Functional Genomics and Human Disease, Monash Institute of Reproduction and Development, Monash University, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/gast.2002.32990DOI Listing
May 2002

Cutaneous lymphomas: which pathological classification?

Pathology 2002 Feb;34(1):36-45

Division of Haematology and Medical Oncology, Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00313020120105615DOI Listing
February 2002